Fake diabetes, multivitamin medicines worth Rs 55 lakh for sale in Delhi, Haryana seized in Himachal Pradesh’s Baddi

Solan : Exposing yet another alleged laxity of the officers of the drug control department, a spurious drugs consignment having costing Rs 55 lakh was seized by a team of drug officials from a transport company vehicle and a pharmaceutical unit premises at Baddi on Sunday.

State Drugs Controller Navneet Marwaha confirmed that a transport godown of RS roadline located at Sai road in Baddi was raided where spurious drugs worth Rs 55 lakh of Sikkim-based Mankind and Intas Pharma pertaining to sugar and multivitamin tablets have been recovered. The said company did not have the license to manufacture these drugs and it had manufactured them in the name of the two companies.

Following this seizure, the manufacturing unit M/s Magnatek enterprise, where the drugs had been manufactured at Baddi was also raided and a huge stock of tablets and scrap were recovered by the team.

Raids were conducted throughout the night. The manufacturing premises of Magnatek enterprise have been sealed while the accused manufacture is absconding.

The vehicle of the transport company was seized in which medicines were being transported by the company. It was found that the firm had sold huge stock of spurious drugs in the market and department proceedings are under investigation to recover all material from the market informed Marwaha.

Drug controller Delhi has also been informed to seize the stock from a Central Delhi based wholesale trader whose bill was recovered from the transport company. The drugs were bound for Delhi and Haryana.

Involvement of other accused in the case is under investigation informed the officials.

Related Posts

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, called on industry leaders at a CII Telangana conference to embed safety by design into manufacturing culture, deploying AI, IoT,…

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Amidst tariff tensions with the US, Europe has created a major opportunity for the Indian pharmaceutical industry. The CDSCO has granted approval to three Indian companies to export APIs to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Researchers discover a compound that can boost ageing muscle repair

Researchers discover a compound that can boost ageing muscle repair

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks